Last $59.79 USD
Change Today +0.46 / 0.78%
Volume 76.2K
HELE On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 2:46 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

helen of troy ltd (HELE) Key Developments

Helen of Troy Limited Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended August 31, 2014; Provides Earnings Guidance for the Second Half and Full Year Ending February 28, 2015

Helen of Troy Limited reported unaudited consolidated earnings results for the second quarter and six months ended August 31, 2014. For the quarter, the company reported, sales revenue, net of $319.949 million, operating income of $24.603 million, income before income taxes of $20.702 million, net income of $18.839 million or $0.65 per diluted share compared to the sales revenue, net of $319.387 million, operating income of $30.356 million, income before income taxes of $28.220 million, net income of $23.318 million or $0.72 per diluted share for the same quarter year ago. For the quarter, on adjusted basis the company reported, operating income of $36.446 million, income before income taxes of $32.545 million, net income of $28.548 million or $0.99 per diluted share compared to the operating income of $39.183 million, income before income taxes of $37.047 million, net income of $31.241 million or $0.97 per diluted share for the same quarter year ago. Adjusted EBITDA was $40.209 million compared to the $41.838 million for the same quarter year ago. For the six months period, the company reported, sales revenue, net of $631.727 million, operating income of $47.726 million, income before income taxes of $40.458 million, net income of $35.237 million or $1.21 per diluted share compared to the sales revenue, net of $623.903 million, operating income of $50.981 million, income before income taxes of $45.987 million, net income of $37.709 million or $1.17 per diluted share for the same period year ago. For the six months period, on adjusted basis the company reported, operating income of $75.123 million, income before income taxes of $67.855 million, net income of $59.311 million or $2.03 per diluted share compared to the operating income of $80.666 million, income before income taxes of $75.672 million, net income of $65.533 million or $2.03 per diluted share for the same quarter year ago. Adjusted EBITDA was $82.156 million compared to the $86.399 million for the same period year ago. The company provided earnings guidance for the second half and full year ending February 28, 2015. For the second half, the company expects to report diluted earnings per share in the range of $2.33 to $2.47 and adjusted diluted earnings per share in the range of $2.83 to $2.97. For the full year, the company expects to report diluted earnings per share in the range of $3.54 to $3.68 and adjusted diluted earnings per share in the range of $4.87 to $5.01. For fiscal year 2015, the company expects net sales revenue excluding Healthy Directions in the range of $1.275 billion to $1.30 billion. The company continues to expect projected sales and diluted EPS (GAAP) from the Healthy Directions acquisition to be in the range of $100 million to $105 million and $0.12 to $0.16. The Company continues to expect adjusted diluted EPS (non-GAAP) excluding Healthy Directions to be in the range of $4.55 to $4.65, which excludes after-tax non-cash asset impairment charges, intangible asset amortization expense, and non-cash share-based compensation expense.

Helen of Troy Limited, Q2 2015 Earnings Call, Oct 09, 2014

Helen of Troy Limited, Q2 2015 Earnings Call, Oct 09, 2014

Helen of Troy Limited to Report Q2, 2015 Results on Oct 09, 2014

Helen of Troy Limited announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Oct 09, 2014

Helen of Troy Limited Revises Earnings Guidance for the Second Quarter and Full Fiscal Year of 2015

Helen of Troy Limited revised earnings guidance for the second quarter and full fiscal year of 2015. For second quarter, the company expects net sales revenue excluding Healthy Directions in the range of $291 to $294 million, and diluted EPS (GAAP) in the range of $0.58 to $0.61. Projected sales from the Healthy Directions acquisition is expected to be in the range of $22 million to $24 million. Healthy Directions' diluted EPS (GAAP) is expected to be in the range of $(0.02) to $0.00, which includes acquisition-related expenses of $0.08 per share, net of tax. Healthy Directions' diluted EPS excluding acquisition-related expenses (non-GAAP), is expected to be in the range of $0.06 to $0.08 for the quarter ended August 31, 2014. Including Healthy Directions, consolidated diluted EPS without significant items (non-GAAP) is expected to be in the range of $0.64 to $0.69 for the quarter ended August 31, 2014. Cash EPS (non-GAAP) excluding Healthy Directions is being introduced in the range of $0.79 to $0.82, which excludes intangible asset amortization expense and non-cash share-based compensation expense. Consolidated cash EPS (non-GAAP) including Healthy Directions is being introduced in the range of $0.87 to $0.92. For the fiscal year 2015, the company expects sales revenue, excluding its Healthy Directions, in the range of $1.275 to $1.30 billion and GAAP EPS of $3.42 to $3.52 per share. Excluding charges, non-GAAP EPS is seen at $3.70 to $3.80 per share, below its prior outlook of $4.30 to $4.40 per share. Projected sales and diluted EPS (GAAP) from the Healthy Directions acquisition is expected to be in the range of $100 million to $105 million and $0.12 to $0.16, respectively, for the remaining eight months of the fiscal year since acquisition. Healthy Directions diluted EPS without significant items (non-GAAP), which excludes acquisition-related expenses of $0.08 per share, is expected to be in the range of $0.20 to $0.24. The company now expects consolidated net sales revenue including Healthy Directions in the range of $1.375 to $1.405 billion. Including Healthy Directions, consolidated diluted EPS excluding significant items (non-GAAP) is now expected to be in the range of $3.90 to $4.04. Cash EPS excluding Healthy Directions is now expected to be in the range of $4.55 to $4.65, which excludes after-tax non-cash asset impairment charges, intangible asset amortization expense, and non-cash share-based compensation expense. This compares to the prior Cash EPS outlook in the range of $5.15 to $5.25, which did not include any impact of the Healthy Directions acquisition. Consolidated cash EPS including Healthy Directions is expected to be in the range of $4.87 to $5.01.

Helen of Troy Limited, 2015 Guidance/Update Call, Sep 02, 2014

Helen of Troy Limited, 2015 Guidance/Update Call, Sep 02, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HELE:US $59.79 USD +0.46

HELE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elizabeth Arden Inc $16.15 USD -0.88
Prestige Brands Holdings Inc $33.65 USD +0.40
Revlon Inc $32.78 USD -0.142
USANA Health Sciences Inc $85.73 USD +0.4091
WD-40 Co $75.02 USD +0.41
View Industry Companies
 

Industry Analysis

HELE

Industry Average

Valuation HELE Industry Range
Price/Earnings 21.9x
Price/Sales 1.3x
Price/Book 2.1x
Price/Cash Flow 20.1x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HELEN OF TROY LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.